Physician profile
John M Simon
NPI 1881628683
$607.58
in general payments reported to CMS, 2019-2025
14 companies · $38.32 in 2025
The $38.32 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $55.02 · 2021: $85.41 · 2022: $20.42 · 2023: $42.81 · 2024: $161 · 2025: $38.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $242.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $94.65 | 2024 | Ovitex 2s |
| Tei Biosciences INC | $84.43 | 2019 | |
| Cook Medical LLC | $72.69 | 2019-2021 | |
| Integra Lifesciences Corporation | $59.25 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $53.23 | 2023-2024 | Xarelto |
| Stryker Corporation | $38.32 | 2025 | Clottriever Bold Catheter |
| Kerecis Limited | $38.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Tei Medical INC. | $33.06 | 2019 | |
| Covidien Lp | $32.18 | 2019 | |
| Smith+Nephew, INC. | $30.70 | 2019-2023 | Collagenase Santyl |
| Kci USA, INC. | $20.64 | 2019 | |
| Medtronic, INC. | $20.42 | 2022 | |
| Allergan, INC. | $16.58 | 2020 | |
| Innocoll Pharmaceuticals Limited | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Simon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.